Citation Impact
Citing Papers
Fatty Acid Labeling from Glutamine in Hypoxia Can Be Explained by Isotope Exchange without Net Reductive Isocitrate Dehydrogenase (IDH) Flux
2013
Interaction of rat plasma very low density lipoprotein with lipoprotein lipase-rich (postheparin) plasma.
1975
The role of increased liver triglyceride content: a culprit of diabetic hyperglycaemia?
2002
Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study.
1992 Standout
Measuring glycerol turnover, gluconeogenesis from glycerol, and total gluconeogenesis with [2-13C]glycerol: Role of the infusion-sampling mode
1996
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Diet–microbiota interactions as moderators of human metabolism
2016 StandoutNature
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
2005 Standout
Functional interactions between the gut microbiota and host metabolism
2012 StandoutNature
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated Dyslipidemia
2010
Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics
1995 Standout
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
2016 Standout
Enolpyruvate: chemical determination as a pyruvate kinase intermediate
1991 StandoutNobel
Effects of fibrates on serum lipids and atherosclerosis
1988
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
1999 Standout
Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.
1995 Standout
A Prospective Study of Moderate Alcohol Consumption and the Risk of Coronary Disease and Stroke in Women
1988 Standout
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
1987 Standout
Radioimmunoassay in Gastroenterology
1972 StandoutNobel
Insulin in blood and insulin antibodies
1966 StandoutNobel
Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
2007 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
The Metabolic Role of Lecithin: Cholesterol Acyltransferase: Perspectives from Pathology
1973
Primary macroglobulinemia
1967
Studies on the Enolization of Pyruvate by Pyruvate Kinase
1960 StandoutNobel
Interconversions and production of volatile fatty acids in the sheep rumen
1965
Metabolism of acetate, propionate and butyrate by sheep-liver slices
1963
Coronary heart disease risk factors in school children: The Muscatine study
1975 Standout
PROSTAGLANDIN-F2α RECEPTOR IN HUMAN CORPORA LUTEA
1974 StandoutNobel
Identification of multiple subclasses of plasma low density lipoproteins in normal humans.
1982
Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
1992 StandoutScience
Energy contributions of volatile fatty acids from the gastrointestinal tract in various species
1990 Standout
Control of Gluconeogenesis in Liver
1967
Measuring gluconeogenesis with [2-13C]glycerol and mass isotopomer distribution analysis of glucose
1995
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
1975 Standout
Factors affecting lipoprotein metabolism.
1965
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Short-Chain Fatty Acids and Human Colonic Function: Roles of Resistant Starch and Nonstarch Polysaccharides
2001 Standout
Immunologic aspects of insulin
1961 StandoutNobel
13C labeling in studies of metabolic regulation
1988
Familial Type IV Hyperlipoproteinemia
1969
Hyperlipidemia in Coronary Heart Disease II. GENETIC ANALYSIS OF LIPID LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIA
1973 StandoutNobel
Acetate utilization in sheep
1961
IMMUNOLOGICAL SPECIFICITY OF HUMAN INSULIN: APPLICATION TO IMMUNOASSAY OF INSULIN
1961 StandoutNobel
On the metabolic conversion of human plasma very low density lipoprotein to low density lipoprotein
1973
Studies on myocardial metabolism
1956
Atherogenesis: a postprandial phenomenon.
1979 Standout
[6] Sequential flotation ultracentrifugation
1986
Inheritance of combined hyperlipoproteinemia: Evidence for a new lipoprotein phenotype
1973
Regulation of Plasma Cholesterol by Lipoprotein Receptors
1981 StandoutScienceNobel
Stereospecific assignment of the methyl 1H NMR lines of valine and leucine in polypeptides by nonrandom 13C labelling
1989 StandoutNobel
Isolated Low HDL Cholesterol As a Risk Factor for Coronary Heart Disease Mortality
1997
Metabolism of [2-14C]acetate and its use in assessing hepatic Krebs cycle activity and gluconeogenesis.
1991
Hyperlipidemia in Coronary Heart Disease III. EVALUATION OF LIPOPROTEIN PHENOTYPES OF 156 GENETICALLY DEFINED SURVIVORS OF MYOCARDIAL INFARCTION
1973 StandoutNobel
Amyloid Deposits and Amyloidosis
1980 Standout
Carbon flux through citric acid cycle pathways in perfused heart by 13C NMR spectroscopy
1987
Effects of glucagon on adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate in human plasma and urine
1970 StandoutNobel
Metabolic relationships among the plasma lipoproteins
1972
Effect of Oleic Acid on the Oxidation and Gluconeogenesis from [1‐14C]Pyruvate in the Perfused Rat Liver
1967
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
1997 Standout
Plasma insulin in man
1960 StandoutNobel
Plasma insulin in health and disease
1961 StandoutNobel
Lipoprotein lipid alterations with cholestyramine administration.
1970
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
1967 Standout
Studies on myocardial metabolism
1955
Thyroid Hormone Regulation of Metabolism
2014 Standout
Phosphorylation of Pyruvate by the Pyruvate Kinase Reaction and Reversal of Glycolysis in a Reconstructed System
1959
THE EFFECT OF GLUCAGON ON CARBOHYDRATE METABOLISM IN NORMAL HUMAN BEINGS 1
1956
Myocardial Metabolism in Diabetes
1957
Quantitation of Hepatic Glycogenolysis And Gluconeogenesis in Fasting Humans With 13 C NMR
1991 Science
The Mechanism of the Osmotic Adjustment of Body Cells as Determined IN VIVO BY THE VOLUME OF DISTRIBUTION OF A LARGE WATER LOAD1
1954
Radioimmunoassay of ACTH in plasma
1968 StandoutNobel
Control of Gluconeogenesis in Liver
1969
Dietary and Drug Treatment of Primary Hyperlipoproteinemia
1972
Aquaglyceroporin AQP9: Solute permeation and metabolic control of expression in liver
2003 StandoutNobel
THE METABOLISM OF ACETIC ACID, PROPIONIC ACID AND BUTYRIC ACID IN SHEEP
1963
Fat Mobilization in Adipose Tissue Is Promoted by Adipose Triglyceride Lipase
2004 StandoutScience
Studies on the Role of Adenosine 3',5'-Monophosphate in the Hepatic Actions of Glucagon and Catecholamines
1971 StandoutNobel
Aggravation of Broad-ß Disease (Type 3 Hyperlipoproteinemia) by Hypothyroidism
1972
Role of Adenosine 3′,5′-Monophosphate in the Effects of Insulin and Anti-insulin Serum on Liver Metabolism
1968 StandoutNobel
Epidemiology as a Guide to Clinical Decisions
1980
Insulin antagonists, insulin antibodies and insulin resistance
1958 StandoutNobel
Influence of Gemfibrozil and Clofibrate on Metabolism of Cholesterol and Plasma Triglycerides in Man
1984
Isotopic Tracers in the Study of Diabetes
1959 StandoutNobel
Hyperlipidemia in Coronary Heart Disease I. LIPID LEVELS IN 500 SURVIVORS OF MYOCARDIAL INFARCTION
1973 StandoutNobel
SPECIES-SPECIFICITY OF HUMAN ANTI-BEEF, PORK INSULIN SERUM
1959 StandoutNobel
The Biochemical, Clinical, and Genetic Features of Type III Hyperlipoproteinemia
1975
Effects of the Thyromimetic Agent Diiodothyropropionic Acid on Body Weight, Body Mass Index, and Serum Lipoproteins: A Pilot Prospective, Randomized, Controlled Study
2010
The Inverse Relation between Fish Consumption and 20-Year Mortality from Coronary Heart Disease
1985 Standout
The mechanism of action of insulin
1955
Current Metabolic-Genetic Interrelationship in Human Atherosclerosis
1968
Evaluation of carbon flux and substrate selection through alternate pathways involving the citric acid cycle of the heart by 13C NMR spectroscopy.
1988
Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia
1972
The use of computers to study rates of lipid metabolism
1969
Studies on the Characterization of Human Serum Lipoproteins Separated by Ultracentrifugation in a Density Gradient
1961
Works of E.H. Strisower being referenced
Glucose Pool and Glucose Space in the Normal and Diabetic Dog
1954
The response of hyperlipoproteinemias to atromid and ethyl chlorophenoxyisobutyrate
1963
Determination of Rates of Glucose Oxidation in Normal and Diabetic Dogs by a Technique Involving Continuous Injection of C14-Glucose
1956
The Separate Hypolipoproteinemic Effects of Dextrothyroxine and Ethyl Chlorophenoxyisobutyrate
1964
Treatment of hyperlipidemias
1968
Waldenström's macroglobulinemia
1962
Partial characterization of serum lipoproteins in the density interval 1.04–1.06 g/ml
1970
Conversion of Fatty Acids to Carbohydrate: Application of Isotopes to this Problem and Role of the Krebs Cycle as a Synthetic Pathway
1957
INCORPORATION OF ACETATE CARBON INTO GLUCOSE BY LIVER SLICES FROM NORMAL AND ALLOXAN-DIABETIC RATS
1952
Treatment of Hyperlipidemic States
1970
Analysis of change in ultracentrifugal lipoprotein profiles following heparin and ethyl-p-chlorophenoxyiso-butyrate administration
1968
THE EFFECT OF INSULIN ON SERUM LIPOPROTEINS OF DIABETIC PATIENTS*
1958
GLUCOSE UTILIZATION IN THE DIABETIC DOG, STUDIED WITH C14-GLUCOSE
1951